Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) Operating Expenses (2023 - 2025)

Camp4 Therapeutics' Operating Expenses history spans 3 years, with the latest figure at $13.1 million for Q4 2025.

  • For Q4 2025, Operating Expenses fell 10.64% year-over-year to $13.1 million; the TTM value through Dec 2025 reached $56.1 million, up 4.3%, while the annual FY2025 figure was $56.1 million, 4.3% up from the prior year.
  • Operating Expenses for Q4 2025 was $13.1 million at Camp4 Therapeutics, down from $14.4 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $14.7 million in Q4 2024 and bottomed at $12.7 million in Q2 2024.
  • The 3-year median for Operating Expenses is $13.5 million (2024), against an average of $13.6 million.
  • The largest YoY upside for Operating Expenses was 14.71% in 2025 against a maximum downside of 10.64% in 2025.
  • A 3-year view of Operating Expenses shows it stood at $12.7 million in 2023, then grew by 15.75% to $14.7 million in 2024, then dropped by 10.64% to $13.1 million in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Operating Expenses are $13.1 million (Q4 2025), $14.4 million (Q3 2025), and $14.5 million (Q2 2025).